Karo Pharma SKr3.4 billion acquisition of Trimb

25/6/2019
Private acquisition

SKr 3.4 billion

$ 366.656 million

Announced

25/6/2019


Overview:

  • Karo Pharma has agreed to acquire Trimb from Avista Capital Partners for approximately SKr3.4 billion.
  • Trimb is a consumer healthcare company based in Stockholm with approximately 90 employees. It owns licenses for, and sells, over-the-counter pharmaceuticals and healthcare products.

Prin Shasiharan - Researcher

 

Jurisdictions:

United States
Sweden
United Kingdom

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: Avista Capital Partners (Seller)

Lawyer: Helen Croke


Party: Karo Pharma (Acquirer)